Clinical characteristics of patients with early-stage NKTCL stratified by treatment and CT regimen
| . | CT alone . | CT + RT . | RT + CT . | ||||||
|---|---|---|---|---|---|---|---|---|---|
| . | New regimens . | Old regimens . | . | New regimens . | Old regimens . | . | New regimens . | Old regimens . | . |
| . | No. (%) . | No. (%) . | P . | No. (%) . | No. (%) . | P . | No. (%) . | No. (%) . | P . |
| Total | 39 | 131 | 118 | 523 | 37 | 172 | |||
| Gender, male | 32 (82.1) | 89 (67.9) | .088 | 82 (69.5) | 366 (70.0) | .917 | 22 (59.5) | 122 (70.9) | .172 |
| Age, >60 y | 9 (23.1) | 19 (14.5) | .205 | 15 (12.7) | 60 (11.5) | .705 | 3 (8.1) | 17 (9.9) | 1.000 |
| B symptoms | 21 (53.8) | 59 (45.0) | .333 | 53 (44.9) | 231 (44.2) | .883 | 21 (56.8) | 62 (36.0) | .020 |
| Elevated LDH | 16 (41.0) | 50 (38.2) | .748 | 35 (29.7) | 185 (35.4) | .238 | 13 (35.1) | 46 (26.7) | .304 |
| ECOG ≥2 | 5 (12.8) | 16 (12.2) | 1.000 | 4 (3.4) | 26 (5.0) | .463 | 1 (2.7) | 11 (6.4) | .697 |
| UADT | 1 (2.6) | 6 (4.6) | 1.000 | 1 (0.8) | 4 (0.8) | 1.000 | 37 (100) | 172 (100) | 1.000 |
| Stage II | 15 (38.5) | 46 (35.7) | .702 | 35 (29.7) | 148 (28.3) | .767 | 13 (35.1) | 27 (15.7) | .006 |
| PTI | 17 (43.6) | 87 (66.4) | .010 | 61 (51.7) | 310 (59.3) | .132 | 27 (73.0) | 87 (50.6) | .013 |
| . | CT alone . | CT + RT . | RT + CT . | ||||||
|---|---|---|---|---|---|---|---|---|---|
| . | New regimens . | Old regimens . | . | New regimens . | Old regimens . | . | New regimens . | Old regimens . | . |
| . | No. (%) . | No. (%) . | P . | No. (%) . | No. (%) . | P . | No. (%) . | No. (%) . | P . |
| Total | 39 | 131 | 118 | 523 | 37 | 172 | |||
| Gender, male | 32 (82.1) | 89 (67.9) | .088 | 82 (69.5) | 366 (70.0) | .917 | 22 (59.5) | 122 (70.9) | .172 |
| Age, >60 y | 9 (23.1) | 19 (14.5) | .205 | 15 (12.7) | 60 (11.5) | .705 | 3 (8.1) | 17 (9.9) | 1.000 |
| B symptoms | 21 (53.8) | 59 (45.0) | .333 | 53 (44.9) | 231 (44.2) | .883 | 21 (56.8) | 62 (36.0) | .020 |
| Elevated LDH | 16 (41.0) | 50 (38.2) | .748 | 35 (29.7) | 185 (35.4) | .238 | 13 (35.1) | 46 (26.7) | .304 |
| ECOG ≥2 | 5 (12.8) | 16 (12.2) | 1.000 | 4 (3.4) | 26 (5.0) | .463 | 1 (2.7) | 11 (6.4) | .697 |
| UADT | 1 (2.6) | 6 (4.6) | 1.000 | 1 (0.8) | 4 (0.8) | 1.000 | 37 (100) | 172 (100) | 1.000 |
| Stage II | 15 (38.5) | 46 (35.7) | .702 | 35 (29.7) | 148 (28.3) | .767 | 13 (35.1) | 27 (15.7) | .006 |
| PTI | 17 (43.6) | 87 (66.4) | .010 | 61 (51.7) | 310 (59.3) | .132 | 27 (73.0) | 87 (50.6) | .013 |